Cargando…

BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays

BPA is a chemical commonly used in the production of polymer-based materials that can have detrimental effects on the thyroid gland and impact human reproductive health. Various expensive methods, such as liquid and gas chromatography, have been suggested for detecting BPA. The fluorescence polariza...

Descripción completa

Detalles Bibliográficos
Autores principales: Raysyan, Anna, Zwigart, Sandro D., Eremin, Sergei A., Schneider, Rudolf J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296492/
https://www.ncbi.nlm.nih.gov/pubmed/37367029
http://dx.doi.org/10.3390/bios13060664
_version_ 1785063663084765184
author Raysyan, Anna
Zwigart, Sandro D.
Eremin, Sergei A.
Schneider, Rudolf J.
author_facet Raysyan, Anna
Zwigart, Sandro D.
Eremin, Sergei A.
Schneider, Rudolf J.
author_sort Raysyan, Anna
collection PubMed
description BPA is a chemical commonly used in the production of polymer-based materials that can have detrimental effects on the thyroid gland and impact human reproductive health. Various expensive methods, such as liquid and gas chromatography, have been suggested for detecting BPA. The fluorescence polarization immunoassay (FPIA) is an inexpensive and efficient homogeneous mix-and-read method that allows for high-throughput screening. FPIA offers high specificity and sensitivity and can be carried out in a single phase within a timeframe of 20–30 min. In this study, new tracer molecules were designed that linked the fluorescein fluorophore with and without a spacer to the bisphenol A moiety. To assess the influence of the C6 spacer on the sensitivity of an assay based on the respective antibody, hapten–protein conjugates were synthesized and assessed for performance in an ELISA setup, and this resulted in a highly sensitive assay with a detection limit of 0.05 g/L. The lowest limit of detection was reached by employing the spacer derivate in the FPIA and was 1.0 μg/L, working range from 2 to 155 μg/L. The validation of the methods was conducted using actual samples compared to LC–MS/MS, which served as the reference method. The FPIA and ELISA both demonstrated satisfactory concordance.
format Online
Article
Text
id pubmed-10296492
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102964922023-06-28 BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays Raysyan, Anna Zwigart, Sandro D. Eremin, Sergei A. Schneider, Rudolf J. Biosensors (Basel) Article BPA is a chemical commonly used in the production of polymer-based materials that can have detrimental effects on the thyroid gland and impact human reproductive health. Various expensive methods, such as liquid and gas chromatography, have been suggested for detecting BPA. The fluorescence polarization immunoassay (FPIA) is an inexpensive and efficient homogeneous mix-and-read method that allows for high-throughput screening. FPIA offers high specificity and sensitivity and can be carried out in a single phase within a timeframe of 20–30 min. In this study, new tracer molecules were designed that linked the fluorescein fluorophore with and without a spacer to the bisphenol A moiety. To assess the influence of the C6 spacer on the sensitivity of an assay based on the respective antibody, hapten–protein conjugates were synthesized and assessed for performance in an ELISA setup, and this resulted in a highly sensitive assay with a detection limit of 0.05 g/L. The lowest limit of detection was reached by employing the spacer derivate in the FPIA and was 1.0 μg/L, working range from 2 to 155 μg/L. The validation of the methods was conducted using actual samples compared to LC–MS/MS, which served as the reference method. The FPIA and ELISA both demonstrated satisfactory concordance. MDPI 2023-06-19 /pmc/articles/PMC10296492/ /pubmed/37367029 http://dx.doi.org/10.3390/bios13060664 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Raysyan, Anna
Zwigart, Sandro D.
Eremin, Sergei A.
Schneider, Rudolf J.
BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
title BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
title_full BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
title_fullStr BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
title_full_unstemmed BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
title_short BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
title_sort bpa endocrine disruptor detection at the cutting edge: fpia and elisa immunoassays
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296492/
https://www.ncbi.nlm.nih.gov/pubmed/37367029
http://dx.doi.org/10.3390/bios13060664
work_keys_str_mv AT raysyananna bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays
AT zwigartsandrod bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays
AT ereminsergeia bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays
AT schneiderrudolfj bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays